Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Denmark Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20102
20112
20132
20162
20203
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Recruiting2
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karen-Lise Garm Spindler2
Vejle Hospital2
Aarhus University Hospital1
Amgen1
Astellas Pharma Inc1
AstraZeneca1
Copenhagen University Hospital at Herlev1
Dorte Nielsen1
Eli Lilly and Company1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis18
Breast Neoplasms4
Neoplasms4
Colorectal Neoplasms3
Prostatic Neoplasms2
Biliary Tract Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Gastrointestinal Neoplasms1
Pancreatic Neoplasms1
Ulcer1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.